NEW THERAPY APPROVED IN SPAIN FOR LUNG CANCER
One of the fastest growing and most aggressive tumors is small cell lung cancer (SCLC), against which there are hardly any robust biomarkers that allow progress in the therapy of choice for these patients. However, in the last days, a new first-line therapy based on immunotherapy was approved in Spain. The drug is an antiPD-L1, […]
NEW THERAPY APPROVED IN SPAIN FOR LUNG CANCER Read More »
